EVALUATION OF BOTULINUM NEUROTOXIN-A IN THE TREATMENT OF MASSETER MUSCLE HYPERTROPHY AMONG A SAMPLE OF IRAQI PATIENTS
loading.default
item.page.date
item.page.authors
item.page.journal-title
item.page.journal-issn
item.page.volume-title
item.page.publisher
Scholar Express Journals
item.page.abstract
Masseteric muscle hypertrophy is considered a benign disease that is characterized by the enlargement of the masseter muscles. Botulinum neurotoxin-A is considered one of the most poisonous biological materials known